Form D · Biotechnology
bluebird bio, Inc.
Cambridge, MA · CIK 0001293971
Offering snapshot reported Sep 21, 2021 · SEC filing
- Reported sold
- $75M Offering amount: $75M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 10, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 21, 2021 | Initial | $74,977,264 | No comparison | 2 | SEC filing |
| Jul 25, 2012 | Initial | $60,000,000 | No comparison | 17 | SEC filing |
| Apr 27, 2011 | Initial | $15,000,000 | No comparison | 5 | SEC filing |
| Apr 27, 2011 | Amendment | $37,500,000 | $8,087,339vs Mar 19, 2010 | 5 | SEC filing |
| Mar 19, 2010 | Initial | $29,412,661 | No comparison | 6 | SEC filing |
| May 17, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 13, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-414037
Source: Form D, filed Sep 21, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Agwunobi | Director |
| Chip Baird | Executive |
| Jason Cole | Executive |
| Wendy Dixon | Director |
| James A. Geraghty | Director |
| Steven Gillis | Director |
| Ramy Ibrahim | Director |
| Nick Leschly | Director, Executive |
| Daniel S. Lynch | Director |
| John M. Maraganore | Director |
| Geert Jan Mulder | Director |
| Axel Polack | Director |
| William R. Sellers | Director |
| Robert Tepper | Director |
| Denice Torres | Director |
| Mark Vachon | Director |
| Jeffrey T. Walsh | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
60 Binney Street
Cambridge, MA, 02142
Cambridge, MA, 02142